Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ENMD-0995 receives orphan drug designation

Nov. 12, 2002

Antitumor activity of TRAIL-R1 MAb demonstrated in vitro and in vivo

Nov. 12, 2002

New antitumor hydroxamates prepared and tested at Ono

Nov. 12, 2002

Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy

Nov. 12, 2002

Cyclis licenses broad technology to expand ACT platform

Nov. 12, 2002

Genzyme initiates kidney cancer clinical trial with innovative vaccine

Nov. 11, 2002

Genta and Aventis initiate two clinical trials with Genasense

Nov. 11, 2002

Phase IIa results show early signs of clinical activity for GCS-100 in pancreatic cancer

Nov. 11, 2002

Icos researchers identify novel inhibitors of CHK1 kinase for use as chemosensitizers

Nov. 11, 2002

December date set for advisory committee review of Bexxar

Nov. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....